Sas Unveils Advanced Ai For Life Sciences Healthcare Sector

52 Days(s) Ago    👁 160
 

SAS Clinical Acceleration Repository is a secure, cloud-native data repository designed to drive innovation in life sciences and healthcare organizations.

It allows clinical researchers to analyze trends, uncover breakthrough treatments, and unlock healthcare insights quickly. The analytics platform manages clinical research data, integrates with data sources, improves clinical trial development, and accelerates regulatory submission.

Streamlining and securing clinical data for innovation

Establishing a secure, advanced data repository to manage clinical data and support clinical trial development from various sources, transforming and preparing it for statistical analytics, and packaging it for regulatory submission is a common challenge for many global companies. Additionally, data management and governance challenges can delay clinical research. SAS Clinical Acceleration Repository provides a modular, open, cloud-native content repository for managing, reporting, sharing, and reviewing data.

The SAS Clinical Acceleration Repository enables researchers and data scientists to better manage their clinical data and empowers organizations to make informed business decisions, said Gail Stephens, Vice President of Healthcare and Life Sciences at SAS. Accelerating and improving the clinical development process helps bring therapies to market sooner and strengthens the bottom line for life sciences and health organizations.

Generating synthetic data to bridge gaps in real-world data

Synthetic data is increasingly being used in the healthcare and life sciences industries to train and test AI systems instead of or in addition to real-world data.